Literature DB >> 31734781

18F-sodium fluoride PET/CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification.

Olivia Sorci1, Alexandra S Batzdorf1, Michael Mayer1, Sylvia Rhodes1, Matthew Peng1, Amanda R Jankelovits1, Julia N Hornyak1, Oke Gerke2, Poul Flemming Høilund-Carlsen2, Abass Alavi1, Chamith S Rajapakse3,4,5.   

Abstract

AIMS: To investigate the benefit of utilizing 18F-sodium fluoride (NaF) PET/CT over calcium and Framingham scoring for potential preventative coronary artery disease (CAD) intervention. METHODS AND
RESULTS: This retrospective study included 136 participants (ages 21-75, BMI 18-43 kg/m2): 86 healthy controls and 50 patients. CT heart segmentations were superimposed onto PET images and standard uptake values (SUV) were calculated by a semi-auto segmentation method of drawing volumes of interest around the heart. Intergroup comparisons were made matching 37 patient/control pairs based on age, gender, and BMI. ROC curves were generated to determine how well SUV and Framingham methods predicted patient status. Regressions including all 136 participants were performed between SUV, age, and BMI. Patients exhibited higher average SUV (SUVmean; P = 0.006) and Framingham scores (P = 0.02) than controls. However, ROC curves indicated that SUVmean could discriminate patients from controls (AUC = 0.63, P = 0.049), but Framingham scores could not (AUC = 0.44, P = 0.38). Calcium scores and maximum SUV (SUVmax) did not differ between patients and controls. SUVmean correlated with age and BMI among females (age, partial R2 = 0.16, P = 0.001; BMI, partial R2 = 0.12, P = 0.004) and males (age, partial R2 = 0.28, P < 0.0001; BMI, partial R2 = 0.22, P < 0.0001).
CONCLUSION: Unlike calcium scores, NaF PET/CT-derived values differed between patients and controls. Framingham risk score patterns echoed those of SUVmean, but were not sensitive enough to predict patient status. SUVmean values increased with age and BMI. Therefore, incorporation of NaF PET/CT into routine prognostic CAD assessment might prove beneficial for assessing early stage plaque calcification in coronary arteries. TRIAL REGISTRATION: ClinicalTrials.gov (NCT01724749).

Entities:  

Keywords:  18F-NaF; Atherosclerosis; Calcification; Coronary artery disease; PET/CT

Mesh:

Substances:

Year:  2019        PMID: 31734781     DOI: 10.1007/s00259-019-04590-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  8 in total

1.  Association between atherosclerotic cardiovascular disease risk score estimated by pooled cohort equation and coronary plaque burden as assessed by NaF-PET/CT.

Authors:  Austin J Borja; Abhijit Bhattaru; Chaitanya Rojulpote; Emily C Hancin; Donald K Detchou; Shivaraj Patil; Karthik Gonuguntla; Pranav Karambelkar; Sree Chinta; Kiranmayi Vuthaluru; Thomas J Werner; Oke Gerke; Poul F Høilund-Carlsen; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

Review 2.  Advances in positron emission tomography tracers related to vascular calcification.

Authors:  Wenjun Yang; Zhiqi Zhong; Guoquan Feng; Zhongqun Wang
Journal:  Ann Nucl Med       Date:  2022-07-14       Impact factor: 2.258

Review 3.  "Vascular inflammation and cardiovascular disease: review about the role of PET imaging".

Authors:  Antonio Maria Sammartino; Raffaele Falco; Andrea Drera; Francesco Dondi; Pietro Bellini; Francesco Bertagna; Enrico Vizzardi
Journal:  Int J Cardiovasc Imaging       Date:  2022-10-18       Impact factor: 2.316

Review 4.  Lipids and cardiovascular calcification: contributions to plaque vulnerability.

Authors:  Jeffrey J Hsu; Yin Tintut; Linda L Demer
Journal:  Curr Opin Lipidol       Date:  2021-10-01       Impact factor: 4.616

Review 5.  Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder.

Authors:  Michael Mayer; Austin J Borja; Emily C Hancin; Thomas Auslander; Mona-Elisabeth Revheim; Mateen C Moghbel; Thomas J Werner; Abass Alavi; Chamith S Rajapakse
Journal:  Front Physiol       Date:  2020-10-22       Impact factor: 4.566

Review 6.  Atherosclerosis Imaging with 18F-Sodium Fluoride PET.

Authors:  Poul F Høilund-Carlsen; Reza Piri; Caius Constantinescu; Kasper Karmark Iversen; Thomas J Werner; Michael Sturek; Abass Alavi; Oke Gerke
Journal:  Diagnostics (Basel)       Date:  2020-10-20

Review 7.  PET-Based Imaging with 18F-FDG and 18F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders.

Authors:  William Y Raynor; Peter Sang Uk Park; Austin J Borja; Yusha Sun; Thomas J Werner; Sze Jia Ng; Hui Chong Lau; Poul Flemming Høilund-Carlsen; Abass Alavi; Mona-Elisabeth Revheim
Journal:  Diagnostics (Basel)       Date:  2021-11-29

8.  Determinants of 18F-NaF uptake in femoral arteries in patients with type 2 diabetes mellitus.

Authors:  Richard A P Takx; Ruth van Asperen; Jonas W Bartstra; Sabine R Zwakenberg; Jelmer M Wolterink; Csilla Celeng; Pim A de Jong; Joline W Beulens
Journal:  J Nucl Cardiol       Date:  2020-03-17       Impact factor: 5.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.